These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 25454677)

  • 1. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: performance improvement by monitoring a new ratio.
    Hall PL; Wittenauer A; Hagar A
    Mol Genet Metab; 2014 Dec; 113(4):274-7. PubMed ID: 25454677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of genotype-phenotype correlations and outcome in MCAD deficiency diagnosed by newborn screening in New York State.
    Arnold GL; Saavedra-Matiz CA; Galvin-Parton PA; Erbe R; Devincentis E; Kronn D; Mofidi S; Wasserstein M; Pellegrino JE; Levy PA; Adams DJ; Nichols M; Caggana M
    Mol Genet Metab; 2010 Mar; 99(3):263-8. PubMed ID: 20036593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood.
    Van Hove JL; Zhang W; Kahler SG; Roe CR; Chen YT; Terada N; Chace DH; Iafolla AK; Ding JH; Millington DS
    Am J Hum Genet; 1993 May; 52(5):958-66. PubMed ID: 8488845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequencing from dried blood spots in infants with "false positive" newborn screen for MCAD deficiency.
    McCandless SE; Chandrasekar R; Linard S; Kikano S; Rice L
    Mol Genet Metab; 2013 Jan; 108(1):51-5. PubMed ID: 23151387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of the most common medium-chain acyl CoA dehydrogenase (MCAD) deficiency mutation (K329E) in the Czech newborn population.
    Kozàk L; Hrabincovà E; Rudolfoà J; Vràbelovà S; Freiberger T
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():49-50. PubMed ID: 11400780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nationwide retrospective observational study of population newborn screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in the Netherlands.
    Jager EA; Kuijpers MM; Bosch AM; Mulder MF; Gozalbo ER; Visser G; de Vries M; Williams M; Waterham HR; van Spronsen FJ; Schielen PCJI; Derks TGJ
    J Inherit Metab Dis; 2019 Sep; 42(5):890-897. PubMed ID: 31012112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correcting false positive medium-chain acyl-CoA dehydrogenase deficiency results from newborn screening; synthesis, purification, and standardization of branched-chain C8 acylcarnitines for use in their selective and accurate absolute quantitation by UHPLC-MS/MS.
    Minkler PE; Stoll MSK; Ingalls ST; Hoppel CL
    Mol Genet Metab; 2017 Apr; 120(4):363-369. PubMed ID: 28190699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: a global perspective.
    Rhead WJ
    J Inherit Metab Dis; 2006; 29(2-3):370-7. PubMed ID: 16763904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry.
    Clayton PT; Doig M; Ghafari S; Meaney C; Taylor C; Leonard JV; Morris M; Johnson AW
    Arch Dis Child; 1998 Aug; 79(2):109-15. PubMed ID: 9797589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biochemical outcomes of patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Anderson DR; Viau K; Botto LD; Pasquali M; Longo N
    Mol Genet Metab; 2020 Jan; 129(1):13-19. PubMed ID: 31836396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborns with C8-acylcarnitine level over the 90th centile have an increased frequency of the common MCAD 985A>G mutation.
    Blois B; Riddell C; Dooley K; Dyack S
    J Inherit Metab Dis; 2005; 28(4):551-6. PubMed ID: 15902558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood acylcarnitine levels in normal newborns and heterozygotes for medium-chain acyl-CoA dehydrogenase deficiency: a relationship between genotype and biochemical phenotype?
    Lehotay DC; LePage J; Thompson JR; Rockman-Greenberg C
    J Inherit Metab Dis; 2004; 27(1):81-8. PubMed ID: 14970748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario.
    Kennedy S; Potter BK; Wilson K; Fisher L; Geraghty M; Milburn J; Chakraborty P
    BMC Pediatr; 2010 Nov; 10():82. PubMed ID: 21083904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening for MCAD deficiency: experience of the first three years in British Columbia, Canada.
    Horvath GA; Davidson AG; Stockler-Ipsiroglu SG; Lillquist YP; Waters PJ; Olpin S; Andresen BS; Palaty J; Nelson J; Vallance H
    Can J Public Health; 2008; 99(4):276-80. PubMed ID: 18767270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of medium-chain acyl-CoA dehydrogenase deficiency detected by newborn screening.
    Hsu HW; Zytkovicz TH; Comeau AM; Strauss AW; Marsden D; Shih VE; Grady GF; Eaton RB
    Pediatrics; 2008 May; 121(5):e1108-14. PubMed ID: 18450854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in The Netherlands: the importance of enzyme analysis to ascertain true MCAD deficiency.
    Derks TG; Boer TS; van Assen A; Bos T; Ruiter J; Waterham HR; Niezen-Koning KE; Wanders RJ; Rondeel JM; Loeber JG; Ten Kate LP; Smit GP; Reijngoud DJ
    J Inherit Metab Dis; 2008 Feb; 31(1):88-96. PubMed ID: 18188679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of MCAD deficiency in Japan: 16years' experience of enzymatic and genetic evaluation.
    Tajima G; Hara K; Tsumura M; Kagawa R; Okada S; Sakura N; Hata I; Shigematsu Y; Kobayashi M
    Mol Genet Metab; 2016 Dec; 119(4):322-328. PubMed ID: 27856190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency.
    Pourfarzam M; Morris A; Appleton M; Craft A; Bartlett K
    Lancet; 2001 Sep; 358(9287):1063-4. PubMed ID: 11589939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method.
    Schmidt-Sommerfeld E; Penn D; Rinaldo P; Kossak D; Li BU; Huang ZH; Gage DA
    Pediatr Res; 1992 Jun; 31(6):545-51. PubMed ID: 1635814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: regional experience and high incidence of carnitine deficiency.
    Couce ML; Sánchez-Pintos P; Diogo L; Leão-Teles E; Martins E; Santos H; Bueno MA; Delgado-Pecellín C; Castiñeiras DE; Cocho JA; García-Villoria J; Ribes A; Fraga JM; Rocha H
    Orphanet J Rare Dis; 2013 Jul; 8():102. PubMed ID: 23842438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.